{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:56:54Z","timestamp":1791579414242,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2917,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.fertnstert.2014.02.039","type":"journal-article","created":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T08:56:38Z","timestamp":1395824198000},"page":"1757-1765.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Influence of oral contraceptives on anthropomorphometric, endocrine, and metabolic profiles of anovulatory polycystic ovary syndrome patients"],"prefix":"10.1016","volume":"101","author":[{"given":"Miranda G.","family":"Mes-Krowinkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne V.","family":"Louwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie G.M.G.J.","family":"Mulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank H.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C.J.M.","family":"Fauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joop S.E.","family":"Laven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2014.02.039_bib1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000194971","article-title":"Obesity and polycystic ovary syndrome","volume":"2","author":"Vrbikova","year":"2009","journal-title":"Obes Facts"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib6","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humupd\/8.3.231","article-title":"Long-term health consequences of PCOS","volume":"8","author":"Wild","year":"2002","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/0022-3859.40778","article-title":"Present status of understanding on the genetic etiology of polycystic ovary syndrome","volume":"54","author":"Dasgupta","year":"2008","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib9","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1472-6483(10)61687-2","article-title":"Influence of oral contraceptive pills on phenotype expression in women with polycystic ovary syndrome","volume":"11","author":"Mulders","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib10","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib11","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00404-010-1790-9","article-title":"Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol-cyproterone acetate","volume":"284","author":"Gode","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib12","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2003-031158","article-title":"Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study","volume":"89","author":"Guido","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0015-0282(02)02993-X","article-title":"Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives","volume":"77","author":"Mastorakos","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/00016348509155112","article-title":"Effects of a low-dose desogestrel-ethinylestradiol combination on hirsutism, androgens and sex hormone binding globulin in women with a polycystic ovary syndrome","volume":"64","author":"Cullberg","year":"1985","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.contraception.2010.04.002","article-title":"Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome","volume":"82","author":"de Leo","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/13625180600983082","article-title":"Efficacy of an oral contraceptive containing drospirenone in the treatment of women with polycystic ovary syndrome","volume":"12","author":"Pehlivanov","year":"2007","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.contraception.2010.01.022","article-title":"Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome","volume":"82","author":"Uras","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/13625180400007751","article-title":"Ethinylestradiol\/cyproterone acetate in polycystic ovary syndrome: lipid and carbohydrate changes","volume":"9","author":"Villaseca","year":"2004","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/00016348509155113","article-title":"Lipid metabolic studies in women with a polycystic ovary syndrome during treatment with a low-dose desogestrel-ethinylestradiol combination","volume":"64","author":"Cullberg","year":"1985","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib20","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/humrep\/15.6.1266","article-title":"Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome","volume":"15","author":"Morin-Papunen","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib21","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.fertnstert.2009.10.016","article-title":"Comparison of effects of 3 mg drospirenone plus 20 \u03bcg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome","volume":"94","author":"Fruzzetti","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/humrep\/17.1.76","article-title":"Insulin sensitivity in nonobese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin","volume":"17","author":"Cibula","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib23","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1365-2265.2002.01518.x","article-title":"FSH and ovarian response: spontaneous recovery of pituitary-ovarian activity during the pill-free period vs. exogenous recombinant FSH during high-dose combined oral contraceptives","volume":"56","author":"van Heusden","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib25","first-page":"2361","article-title":"Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"83","author":"Imani","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib26","first-page":"540","article-title":"Detection of minimal levels of serum anti-Mullerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay","volume":"85","author":"Long","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0022-3565(25)22688-X","article-title":"Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells","volume":"240","author":"Lamberts","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib28","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1210\/en.2005-1588","article-title":"Serum antimullerian hormone levels reflect the size of the primordial follicle pool in mice","volume":"147","author":"Kevenaar","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib29","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1210\/jc.2007-1756","article-title":"A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study","volume":"93","author":"Valkenburg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/jc.2010-0130","article-title":"Hyperandrogenism in women with polycystic ovary syndrome persists after menopause","volume":"96","author":"Markopoulos","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib32","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.contraception.2010.02.009","article-title":"Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome","volume":"82","author":"Kriplani","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib34","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.fertnstert.2009.05.044","article-title":"Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study","volume":"94","author":"Battaglia","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib35","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/humrep\/deh373","article-title":"Changes in anti-m\u00fcllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility","volume":"19","author":"Mulders","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejogrb.2007.01.012","article-title":"Anti-Mullerian hormone levels during hormonal contraception in women with polycystic ovary syndrome","volume":"134","author":"Somunkiran","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1472-6483(10)61747-6","article-title":"Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility","volume":"7","author":"Mulders","year":"2003","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humupd\/dmr001","article-title":"PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis","volume":"17","author":"de Groot","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.maturitas.2003.10.013","article-title":"Biology: risk factor modification by OCs and HRT lipids and lipoproteins","volume":"47","author":"Godsland","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib40","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.2007-0282","article-title":"Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome","volume":"92","author":"Luque-Ramirez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1210\/rp.59.1.207","article-title":"Obesity, insulin resistance, and cardiovascular disease","volume":"59","author":"Reaven","year":"2004","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib42","first-page":"CD003987","article-title":"Combination contraceptives: effects on weight","author":"Gallo","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib43","first-page":"CD006133","article-title":"Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus","author":"Lopez","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2014.02.039_bib44","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0020-7292(97)00239-7","article-title":"Low-dose oral contraceptives and 24-hour ambulatory blood pressure","volume":"59","author":"Cardoso","year":"1997","journal-title":"Int J Gynaecol Obstet"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214001927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214001927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:12:23Z","timestamp":1758010343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028214001927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0015028214001927"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.02.039","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of oral contraceptives on anthropomorphometric, endocrine, and metabolic profiles of anovulatory polycystic ovary syndrome patients","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.02.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}